Navigation Links
Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019

FORT WORTH, Texas, April 20, 2015 /PRNewswire/ --

Orthobiologics are substances that are utilized by orthopedic surgeons for healing bone injuries. The orthobiologics market is a rewarding market, which represents a number of growth opportunities for its stakeholders. The global orthobiologics market report defines and segments the concerned market with analysis and forecast of revenue. The global orthobiologics market was valued at $5,712.4 million in 2014, and is projected to reach $7,900.2 million by 2019, at a CAGR of 6.7% from 2014 to 2019.

Browse through the TOC of global orthobiologics market for an in-depth analysis of the industry trends and segments, with help of various tables and figures.

Early buyers will receive 10% customization on this report.  

The changing preference from mechanical to biological implants, accompanied by the rising awareness of orthobiologics is expediting the growth of this market. The orthobiologics market has seen an impressive growth since 2012, owing to increased research and development activities and rising demand for orthobiologics products.

North America contributes the largest market share in the global orthobiologics market, and is slated to grow further due to recent advancements made in the field of orthopedics. On the other hand, Asia is the fastest growing region in the global orthobiologics market by virtue of its exponential aging population as well as rising prevalence of diabetes and obesity.

Inquiry Before Buying @

The global orthobiologics market is segmented on the basis of product, end-user, and geography. According to geographical segmentation, this market is classified into North America, Europe, Asia, and the rest of the world (RoW).

This report provides a comprehensive overview of market share and value chain analysis, in addition to in-depth insights on varied market metrics such as drivers, restraints and upcoming opportunities. The report also presents a competitive landscape and company profiles of key players in the market. Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.), Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.) are some of the leading players in the global orthobiologics market.

Related Reports: 

The North America Orthobiologics Market was valued at $1,724.5 million in 2014, and is expected to reach $2,493.5 million by 2019 at a CAGR of 7.7% from 2014 to 2019. The North American orthobiologics market has been segmented on the basis of product, end-user, and country. Orthobiologics market comprises products such as bone graft substitutes, stem cell therapy, bone allografts, viscosupplementation, and bone growth factor & spinal stimulation. The market has been further segmented on the basis of end-users into hospitals, Point of Care (POC) testing, and other end users. The North America Orthobiologics market consists of countries such as the U.S., Canada, and Mexico.

Report Subscription: 

MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.

About MicroMarket Monitor: 

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Mr. Chandrasekhar K. 
5601 Bridge Street 
Suite 300 
Fort Worth, TX 76112 
Tel: +1-888-502-0539 

SOURCE MicroMarket Monitor
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Global Stem Cells Group to Host Featured Speaker at The Aesthetic Meeting 2015 in Montreal
2. Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015
3. Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development
4. SELLAS Life Sciences Group and TrojanTec Sign Exclusive License Agreement for Global Rights on Development and Commercialization of Innovative TR-1 Anti-Cancer Antennapedia Technology
5. SQI Delivers Sqidlite System to Global Pharmaceutical Customer
6. Strand Life Sciences Names Scott Storrer to Expanded Leadership Position of Global President and Introduces U.S. Management Team
7. Agreements & Partnerships, a Key Strategy Adopted by Leading Market Players to Foster their Growth in the Global Oncology Information System Market - MarketsandMarkets
8. Engage Global and Premier Micronutrient Corporation Announce Strategic Partnership
9. Global miRNA Market Outlook to 2018
10. Actinobac Biomed Selected to Present at Cavendish Global Health Impact Forum
11. Report: Global Market for Dialysis Care Nears 90 Billion Dollars
Post Your Comments:
(Date:9/30/2019)... , ... September 30, 2019 , ... ... science newsletter from Rigaku Corporation , is now available online on the ... X-ray based materials science, including X-ray diffraction, fluorescence and imaging, and presents articles, ...
(Date:9/24/2019)... ... 24, 2019 , ... Personalized Stem Cells, Inc ... for clinical trial sites and physician investigators. The clinical trial sites are ... , Clinical trial sites are currently located in San Diego and Los Angeles ...
(Date:9/17/2019)... ... 17, 2019 , ... Catalent, a global leader in clinical ... Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials ... On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s ...
(Date:9/17/2019)... WHITEHOUSE STATION, N.J. (PRWEB) , ... September 16, 2019 , ... ... tissue clearing reagents and kits that allow for the complete 3D characterization of tissues ... years, Visikol has transitioned into an imaging, image analysis and advanced cell culture focused ...
Breaking Biology Technology:
(Date:9/24/2019)... , ... September 23, 2019 , ... ... in Cambridge, MA, announce today that Holotype HLA and other Omixon products will ... of the American Society for Histocompatibility and Immunogenetics (ASHI) in Pittsburgh, ...
(Date:9/24/2019)... ... September 24, 2019 , ... Lajollacooks4u, San Diego’s premiere team-building ... five-star reviews on the popular travel review site, TripAdvisor. , Recent reviews call ... food” and “unique local experience.” These sentiments have not only led the way ...
(Date:9/17/2019)... ... September 17, 2019 , ... Last week, ... and engineers from the Medical University of Warsaw, met at the Presidential Palace ... in creating a neuroprosthetic system as part of an initiative called "Startups in ...
Breaking Biology News(10 mins):